Evidence map›Paper›PMID 41663474›Full record

ArticleScientific reports2026

Lifetime MDMA use and associations with meaning in life in the context of childhood trauma.

Michelle Olofsson, Kasim Acar, Otto Simonsson, Maria Bragesjö, Tonya White, Rita Almeida, Predrag Petrovic, Alexander Lebedev

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michelle Olofsson *Center for Psychiatry Research & Center for Cognitive Neuropsychiatry, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Kasim Acar *Center for Psychiatry Research & Center for Cognitive Neuropsychiatry, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Otto SimonssonDepartment of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Maria BragesjöCenter for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services, Stockholm, Region Stockholm, Sweden.
Tonya WhiteSection on Social and Cognitive Developmental Neuroscience, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Rita AlmeidaStockholm University Brain Imaging Center, Stockholm University, Stockholm, 114 18, Sweden.
Predrag PetrovicCenter for Psychiatry Research & Center for Cognitive Neuropsychiatry, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. predrag.petrovic@ki.se.
Alexander LebedevCenter for Psychiatry Research & Center for Cognitive Neuropsychiatry, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent research has highlighted the potential of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for the treatment of post-traumatic stress disorder and other trauma-related psychiatric conditions. However, less is known about the effects of MDMA use on psychological well-being in populations with trauma histories outside of clinical contexts. In the present study, we assessed associations between naturalistic lifetime MDMA use (i.e., having ever used MDMA) and an overlooked psychological predictor of resilience – meaning in life. Using data from a survey study of a sample of Swedish adults (n = 807), multiple linear regression models were fit to assess associations between lifetime MDMA use and meaning in life, as well as interactions with childhood trauma history. Meaning in life was measured using the presence subscale of the 10-item meaning in life questionnaire (MLQ). While lifetime MDMA use was not significantly associated with meaning in life overall (β = 1.80, p = 0.055), a significant interaction emerged between lifetime MDMA use and childhood trauma on meaning in life (β = 4.06, p = 0.012). Specifically, MDMA use was associated with higher meaning in life among individuals with a history of childhood trauma. Together, these associations warrant further longitudinal and experimental research to test whether MDMA exposure relates to changes in meaning in life.

Indexed as

Adverse Childhood ExperiencesN-Methyl-3,4-methylenedioxyamphetamineStress Disorders, Post-TraumaticAdultFemaleHallucinogensHumansMaleMiddle AgedSurveys and QuestionnairesSwedenYoung AdultHallucinogensN-Methyl-3,4-methylenedioxyamphetamineChildhoodMDMAMeaningPsychedelicsPurposeTrauma

Identifiers

PMID41663474
PMCPMC12891599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.